Eleventh Meeting of the National Clinical Care Commission, 23731 [2021-09277]

Download as PDF Federal Register / Vol. 86, No. 84 / Tuesday, May 4, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Eleventh Meeting of the National Clinical Care Commission Office on Women’s Health, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The National Clinical Care Commission (the Commission) will conduct its eleventh meeting virtually on May 19 and June 1, 2021. The Commission is charged to evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to diabetes and its complications. DATES: The two-day meeting will take place May 19 and June 1, 2021 from 1 p.m. to approximately 6 p.m. Eastern Time (ET). ADDRESSES: The meeting will be held online via webinar. To register to attend the meeting, please visit the registration website at https:// kauffmaninc.adobeconnect.com/ ncccmeeting11/event/event_info.html. FOR FURTHER INFORMATION CONTACT: Kara Elam, Ph.D., MPH, MS, Designated Federal Officer, National Clinical Care Commission, U.S. Department of Health and Human Services, Office on Women’s Health, 200 Independence Ave. SW, 7th Floor, Washington, DC 20201, Phone: (240) 435–9438, Email: Kara.Elam@hhs.gov. SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act (Pub. L. 115–80) requires the HHS Secretary to establish the National Clinical Care Commission. The Commission consists of representatives of specific federal agencies and nonfederal individuals who represent diverse disciplines and views. The Commission will evaluate and make recommendations to the HHS Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to diabetes and its complications. The eleventh meeting will be held virtually, and each subcommittee will present a summary of stakeholder calls and all draft recommendations. This will be followed by a discussion of the recommendations. The final meeting agenda will be available prior to the meeting at https://health.gov/our-work/ health-care-quality/national-clinicalcare-commission/meetings. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:13 May 03, 2021 Jkt 253001 23731 Authority: The National Clinical Care Commission is required under the National Clinical Care Commission Act (Pub. L. 115– 80). The Commission is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Early Phase Psychosocial and Confirmatory Efficacy Clinical Trials. Date: June 2, 2021. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6143, MSC 9606, Bethesda, MD 20892–9606, 301–443–9699, bursteinme@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Effectiveness Studies. Date: June 3, 2021. Time: 11:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Nicholas Gaiano, Ph.D., Review Branch, Chief Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center/Room 6150/MSC 9606, 6001 Executive Boulevard, Bethesda, MD 20892–9606, 301–443–2742, nick.gaiano@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: April 27, 2021. Dorothy A. Fink, Deputy Assistant Secretary for Women’s Health. Dated: April 29, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–09277 Filed 5–3–21; 8:45 am] [FR Doc. 2021–09375 Filed 5–3–21; 8:45 am] BILLING CODE 4150–32–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Public Participation at Meeting: The Commission invites public comment on issues related to the Commission’s charge. There will be an opportunity for limited oral comments (each no more than 3 minutes in length) at this virtual meeting. Virtual attendees who plan to provide oral comments at the Commission meeting during a designated time must register prior to the meeting at https:// kauffmaninc.adobeconnect.com/ ncccmeeting11/event/event_info.html. Written comments are welcome throughout the entire development process of the Commission’s work and may be emailed to OHQ@hhs.gov. Written comments should not exceed three pages in length. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate the special accommodation when registering online or by notifying Jennifer Gillissen at jennifer.gillissen@ kauffmaninc.com by May 10, 2021. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 86, Number 84 (Tuesday, May 4, 2021)]
[Notices]
[Page 23731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09277]



[[Page 23731]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Eleventh Meeting of the National Clinical Care Commission

AGENCY: Office on Women's Health, Office of the Assistant Secretary for 
Health, Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct its eleventh meeting virtually on May 19 and June 1, 2021. The 
Commission is charged to evaluate and make recommendations to the U.S. 
Department of Health and Human Services (HHS) Secretary and Congress 
regarding improvements to the coordination and leveraging of federal 
programs related to diabetes and its complications.

DATES: The two-day meeting will take place May 19 and June 1, 2021 from 
1 p.m. to approximately 6 p.m. Eastern Time (ET).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/ncccmeeting11/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: Kara Elam, Ph.D., MPH, MS, Designated 
Federal Officer, National Clinical Care Commission, U.S. Department of 
Health and Human Services, Office on Women's Health, 200 Independence 
Ave. SW, 7th Floor, Washington, DC 20201, Phone: (240) 435-9438, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals who represent 
diverse disciplines and views. The Commission will evaluate and make 
recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.
    The eleventh meeting will be held virtually, and each subcommittee 
will present a summary of stakeholder calls and all draft 
recommendations. This will be followed by a discussion of the 
recommendations. The final meeting agenda will be available prior to 
the meeting at https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be an 
opportunity for limited oral comments (each no more than 3 minutes in 
length) at this virtual meeting. Virtual attendees who plan to provide 
oral comments at the Commission meeting during a designated time must 
register prior to the meeting at https://kauffmaninc.adobeconnect.com/ncccmeeting11/event/event_info.html.
    Written comments are welcome throughout the entire development 
process of the Commission's work and may be emailed to [email protected]. 
Written comments should not exceed three pages in length.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by May 10, 2021.

    Authority: The National Clinical Care Commission is required 
under the National Clinical Care Commission Act (Pub. L. 115-80). 
The Commission is governed by provisions of the Federal Advisory 
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) 
which sets forth standards for the formation and use of federal 
advisory committees.

    Dated: April 27, 2021.
Dorothy A. Fink,
Deputy Assistant Secretary for Women's Health.
[FR Doc. 2021-09277 Filed 5-3-21; 8:45 am]
BILLING CODE 4150-32-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.